Literature DB >> 17917008

Immunology today and new discoveries: building upon legacies of Dr. Robert A. Good.

Fred Modell1.   

Abstract

Mesh:

Year:  2007        PMID: 17917008     DOI: 10.1007/s12026-007-0049-4

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


× No keyword cloud information.
  7 in total

1.  Global study of primary immunodeficiency diseases (PI)--diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell Foundation.

Authors:  Vicki Modell; Bonnie Gee; David B Lewis; Jordan S Orange; Chaim M Roifman; John M Routes; Ricardo U Sorensen; Luigi D Notarangelo; Fred Modell
Journal:  Immunol Res       Date:  2011-10       Impact factor: 2.829

2.  Modeling strategy to identify patients with primary immunodeficiency utilizing risk management and outcome measurement.

Authors:  Vicki Modell; Jessica Quinn; Grant Ginsberg; Ron Gladue; Jordan Orange; Fred Modell
Journal:  Immunol Res       Date:  2017-06       Impact factor: 2.829

3.  From genotype to phenotype. Further studies measuring the impact of a Physician Education and Public Awareness Campaign on early diagnosis and management of primary immunodeficiencies.

Authors:  Fred Modell; Diana Puente; Vicki Modell
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

4.  Primary immunodeficiencies worldwide: an updated overview from the Jeffrey Modell Centers Global Network.

Authors:  Vicki Modell; Jessica Quinn; Jordan Orange; Luigi D Notarangelo; Fred Modell
Journal:  Immunol Res       Date:  2016-06       Impact factor: 2.829

5.  Global overview of primary immunodeficiencies: a report from Jeffrey Modell Centers worldwide focused on diagnosis, treatment, and discovery.

Authors:  Vicki Modell; Megan Knaus; Fred Modell; Chaim Roifman; Jordan Orange; Luigi D Notarangelo
Journal:  Immunol Res       Date:  2014-10       Impact factor: 2.829

6.  Global report on primary immunodeficiencies: 2018 update from the Jeffrey Modell Centers Network on disease classification, regional trends, treatment modalities, and physician reported outcomes.

Authors:  Vicki Modell; Jordan S Orange; Jessica Quinn; Fred Modell
Journal:  Immunol Res       Date:  2018-06       Impact factor: 2.829

7.  Exome Sequencing Identifies a Novel MAP3K14 Mutation in Recessive Atypical Combined Immunodeficiency.

Authors:  Nikola Schlechter; Brigitte Glanzmann; Eileen Garner Hoal; Mardelle Schoeman; Britt-Sabina Petersen; Andre Franke; Yu-Lung Lau; Michael Urban; Paul David van Helden; Monika Maria Esser; Marlo Möller; Craig Kinnear
Journal:  Front Immunol       Date:  2017-11-27       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.